Jobs

The pharmaceutical industry found it harder to fill cybersecurity vacancies in Q1 2022

The proportion of pharmaceutical companies hiring for cloud related positions rose to a year-high in August 2021, with 42.7% of the companies included in our analysis recruiting for at least one such position.

Related jobs in North America that were taken offline in Q1 2022 had been online for an average of 45.6 days.

Powered by 

Cybersecurity related jobs that were closed during Q1 2022 had been online for an average of 43 days when they were taken offline. 

This was an increase compared to the equivalent figure a year earlier, indicating that the required skillset for these roles has become harder to find in the past year. 

Cybersecurity is one of the topics that GlobalData, our parent company and from whom the data for this article is taken, have identified as being a key disruptive technology force facing companies in the coming years. Companies that excel and invest in these areas now are thought to be better prepared for the future business landscape and better equipped to survive unforeseen challenges.

On a regional level, these roles were hardest to fill in North America, with related jobs that were taken offline in Q1 2022 having been online for an average of 45.6 days. 

The next most difficult place to fill these roles was found to be Europe, while Asia-Pacific was in third place. 

At the opposite end of the scale, jobs were filled fastest in the Middle East and Africa, with adverts taken offline after eight days on average.

While the pharmaceutical industry found it harder to fill these roles in the latest quarter, these companies also found it harder to recruit cybersecurity jobs than the wider market, with ads online for 26.5% more time on average compared to similar jobs across the entire jobs market. 

GlobalData's job analytics database tracks the daily hiring patterns of thousands of companies across the world, drawing in jobs as they're posted and tagging them with additional layers of data on everything from the seniority of each position to whether a job is linked to wider industry trends.

Go to article: Home | How delays derailed Covid-19 vaccination in AfricaGo to article: In this issueGo to article: ContentsGo to article: CSafe GlobalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: SHL MedicalGo to article: Stormy StudioGo to article: CommentGo to article: It will take years for AI use to peak in drug discovery and development processGo to article: Bear market hits Europe’s innovator drug venture financing, losing pace with USGo to article: Longevity technology and its futureGo to article: Potential impact on women’s healthcare post-Roe versus WadeGo to article: Dupixent approval brings first biologic to youngest atopic dermatitis patientsGo to article: BioLife SolutionsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: In DepthGo to article: How delays derailed Covid-19 vaccination in AfricaGo to article: Is pharma doing enough to tackle the opioid epidemic?Go to article: Decoding the Covid-19 connection with diabetesGo to article: CAR-Ts in China: the dawn of an immunotherapy superpowerGo to article: Drawing on data to make oncology trials diverseGo to article: NiproGo to article: BEA TechnologiesGo to article: In DataGo to article: The pharmaceutical industry found it harder to fill cybersecurity vacancies in Q1 2022Go to article: Debt offerings decreased significantly in the pharmaceutical industry in H2 2021Go to article: Partnerships decreased in the pharmaceutical industry in H2 2021Go to article: Europe is seeing a hiring boom in pharmaceutical industry big data rolesGo to article: EventsGo to article: Next issue